AUROPHARMA Corporate Action

Aurobindo Pharma Ltd Share Price

AUROPHARMA

Trade

NSE

CMP as on 26-May-23 3:59
₹ 615

9.85 | 1.63%

Open
₹ 591

Turnover(lac)
₹ 9,658

Prev. Close
₹ 605.00

Day's Vol (shares)
₹ 1,570,786

Day's Vol (shares)

₹ 591.25 ₹ 618.00

BSE

CMP as on 26-May-23 3:44
₹ 615

9.55 | 1.58%

Open
₹ 600

Turnover(lac)
₹ 249

Prev. Close
₹ 605.00

Day's Vol (shares)
₹ 57,391

Day's Vol (shares)

₹ 596.45 ₹ 617.45

FUTURE

CMP as on 26-May-23 12:00
₹ 618

9.20 | 1.51%

Open
₹ 604

Open Interest(Contracts)
₹ 9,195,000

VWAP
₹ 609.59

Day's Vol (shares)
₹ 3,287,000

Day's Vol (shares)
₹ 600.50 ₹ 619.60

Corporate Action

Action :

From Date:

To Date:

Purpose	AGM Date	Announcement Date	Book Closure Start Date	Book Closure End Date
AGM	02-Aug-2022	07-Jul-2022	-	-
AGM 02/08/2022 Source : Business Standard Date : 11.07.2022 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the copies of the Notice published in the newspapers, Business Standard and Nava Telangana on 08.07.2022, intimating the shareholders that the 35th Annual General Meeting of the Company will be held on Tuesday, August 2, 2022 at 3.30 PM (1ST) through Video Conferencing / Other Audio Visual Means. Pursuant to Section 91 of the Companies Act, 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Register of Members and Share Transfer Books will remain closed from Friday, July 29, 2022 to Tuesday, August 2, 2022 (both days inclusive). (As Per BSE Announcement dated on 08.07.2022) In continuation to our letter dated July 7, 2022, the 35th Annual General Meeting (AGM) of the Company was held on August 2, 2022 and the business mentioned in the AGM Notice dated June 17, 2022 was transacted. In this regard, please find enclosed the following: 1. Summary of proceedings as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure- I. 2. Voting Results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure-II. 3. The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) as Annexure- III. Aurobindo Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement dated on 03.08.2022)

AUROPHARMA Corporate Action

Aurobindo Pharma Ltd Share Price

AUROPHARMA

NSE

9.85 | 1.63%

BSE

9.55 | 1.58%

FUTURE

9.20 | 1.51%

Action :

QuickLinks for Aurobindo Pharma Ltd.

Aurobindo Pharma Information

Aurobindo Pharma Financials

Aurobindo Pharma Results

Aurobindo Pharma News

IIFL Customer Care Number

1860-267-3000 /7039-050-000

IIFL Securities Support Whatsapp Number

+91-9892691696

Download The App Now

IIFL Customer Care Number

1860-267-3000 /7039-050-000

IIFL Securities Support Whatsapp Number

+91-9892691696

Download The App Now

MARKET

IDEAS

MUTUAL FUNDS

TRADING DOCUMENTATION

CALCULATOR

GLOSSARY (A-Z)